{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T13:25:27Z","timestamp":1774013127380,"version":"3.50.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:p>Bietti crystalline dystrophy (BCD) is a rare heritable retinal disease characterized by crystal deposition primarily in the retina. It is associated with atrophy of the retinal pigment epithelium (RPE) and is caused by variants in <jats:italic toggle=\"yes\">CYP4V2<\/jats:italic>, which encodes a cytochrome P450 hemethiolate protein superfamily member. CYP4V2 is involved in the selective hydrolysis of saturated medium chain fatty acids, and patients with BCD demonstrate abnormalities in fatty acid metabolism, including abnormal lipid profiles and the accumulation of the pathogenic crystals within the RPE, which leads to the visual pathologies characteristic of BCD. However, the precise identity of the crystals is currently unknown, and BCD has no established extraocular manifestations. Here, we report granulomatous hepatitis associated with abundant diffuse crystalline clefts in the hepatic parenchyma in 3 patients with retinal dystrophy and dyslipidemia: 2 with pathogenic CYP4V2 variants and 1 patient with clinical ophthalmologic findings suggestive of BCD but without available genetic testing. The unique and striking histologic features unifying the liver biopsies in all 3 patients strongly support a process related to abnormal fatty acid metabolism underlying the genetic disease of BCD, expanding the spectrum of BCD and shedding light on the importance of CYP4V2 in systemic fatty acid metabolism.<\/jats:p>","DOI":"10.1097\/pas.0000000000002253","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T05:00:07Z","timestamp":1716872407000},"page":"1138-1145","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Crystalline Hepatopathy Associated With Bietti Crystalline Dystrophy: A Striking Manifestation of Disordered Fatty Acid Metabolism"],"prefix":"10.1097","volume":"48","author":[{"given":"Ben W.","family":"Dulken","sequence":"first","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorukhan","family":"Bahceci","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loh-Shan","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Stanford University School of Medicine, Stanford"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Stanford University School of Medicine, Stanford"},{"name":"Molecular Surgery Laboratory, Stanford University"},{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Tak","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena Y.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00006982-200406000-00013","article-title":"Bietti\u2019s crystalline corneoretinal dystrophy: A cross-sectional study","volume":"24","author":"Matafsi","year":"2004","journal-title":"Retina"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1167\/iovs.05-0378","article-title":"Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations","volume":"46","author":"Lee","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ophtha.2013.11.042","article-title":"Detailed phenotypic and genotypic characterization of Bietti crystalline dystrophy","volume":"121","author":"Halford","year":"2014","journal-title":"Ophthalmology"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0002-9394(14)76572-9","article-title":"Clinical biochemical and pathologic correlations in Bietti\u2019s crystalline dystrophy","volume":"118","author":"Kaiser-Kupfer","year":"1994","journal-title":"American J Opthalmol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0002-9297(07)62960-7","article-title":"Genetic linkage of Bietti crystalline corneoretinal dystrophy to chromosome 4q35","volume":"67","author":"Jiao","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1086\/383228","article-title":"Bietti Crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2","volume":"74","author":"Li","year":"2004","journal-title":"Am J Hum Genet"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1136\/jmg.2004.029066","article-title":"Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy","volume":"42","author":"Lin","year":"2005","journal-title":"J Med Genet"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"e94960","DOI":"10.1371\/journal.pone.0094960","article-title":"Molecular analysis and phenotypic study in 14 Chinese families with Bietti crystalline dystrophy","volume":"9","author":"Yin","year":"2014","journal-title":"PLoS ONE"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jmg.24.10.584","article-title":"Prevalence and mode of inheritance of major genetic eye diseases in China","volume":"24","author":"Hu","year":"1987","journal-title":"J Med Genet"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/ceo.13875","article-title":"Molecular diagnosis based on comprehensive genetic testing in 800 Chinese families with non-syndromic inherited retinal dystrophies","volume":"49","author":"Liu","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2011.04.112","article-title":"Identification of CYP4V2 mutation in 21 families and overview of mutation spectrum in Bietti crystalline corneoretinal dystrophy","volume":"409","author":"Xiao","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/ijms17050588","article-title":"Herbal Hepatotoxicity: Clinical characteristics and listing compilation","volume":"17","author":"Frenzel","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4321\/S1130-01082005000200006","article-title":"Hepatotoxicity associated with the ingestion of Centella asiatica","volume":"97","author":"Jorge","year":"2005","journal-title":"Rev Esp Enferm Dig"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ejhg.2016.184","article-title":"Identification and population history of CYP4V2 mutations in patients with Bietti crystalline corneoretinal dystrophy","volume":"25","author":"Jiao","year":"2017","journal-title":"Eur J Human Gen"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s41433-023-02791-7","article-title":"Longitudinal structure-function analysis of molecularly-confirmed CYP4V2 Bietti crystalline dystrophy","volume":"38","author":"Cheloni","year":"2023","journal-title":"Eye"},{"key":"R16-20250608","first-page":"9","article-title":"Evolution of cellular inclusions in Bietti\u2019s crystalline dystrophy","volume":"2010","author":"Furusato","year":"2010","journal-title":"Ophthalmol Eye Dis"},{"key":"R17-20250608","first-page":"164","article-title":"Bietti\u2019s tapetoretinal degeneration with marginal corneal dystrophy crystalline retinopathy","author":"Welch","year":"1977","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep4.1348","article-title":"Cholesterol crystals in hepatocyte lipid droplets are strongly associated with human nonalcoholic steatohepatitis","volume":"3","author":"Ioannou","year":"2019","journal-title":"Hepatol Commun"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J Lipid Res"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1167\/iovs.13-13717","article-title":"Generation and characterization of a murine model of Bietti crystalline dystrophy","volume":"55","author":"Lockhart","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1124\/dmd.109.028530","article-title":"Expression and characterization of CYP4V2 as a fatty acid \u03c9-hydroxylase","volume":"37","author":"Nakano","year":"2009","journal-title":"Drug Metab Disp"},{"key":"R22-20250608","first-page":"1707","article-title":"The metabolism of fatty acids in human Bietti crystalline dystrophy","volume":"42","author":"Lee","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1167\/iovs.09-3665","article-title":"Alterations in serum fatty acid concentrations and desaturase activities in Bietti crystalline dystrophy unaffected by CYP4V2 genotypes","volume":"51","author":"Lai","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/mgme.1998.2723","article-title":"Identification, isolation, and characterization of a 32-kDa fatty acid-binding protein missing from lymphocytes in humans with Bietti crystalline dystrophy (BCD)","volume":"65","author":"Lee","year":"1998","journal-title":"Mol Genet Metab"},{"key":"R25-20250608","first-page":"1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science (1979)"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.12998\/wjcc.v10.i28.10346","article-title":"Relationship of familial cytochrome P450 4V2 gene mutation with liver cirrhosis: A case report and review of the literature","volume":"10","author":"Jiang","year":"2022","journal-title":"World J Clin Cases"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/112067210701700434","article-title":"Long-term follow-up in Bietti crystalline dystrophy","volume":"17","author":"Mansour","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.2147\/OPTH.S185744","article-title":"Current perspectives in Bietti crystalline dystrophy","volume":"13","author":"Garc\u00eda-Garc\u00eda","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/ddh048","article-title":"Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: A reappraisal of the human disease sequence","volume":"13","author":"Cideciyan","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13090222","article-title":"Nonalcoholic fatty liver disease (NAFLD) and hepatic cytochrome p450 (CYP) enzymes","volume":"13","author":"Jamwal","year":"2020","journal-title":"Pharmaceuticals"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"114841","DOI":"10.1016\/j.bcp.2021.114841","article-title":"CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD)","volume":"195","author":"Osborne","year":"2022","journal-title":"Biochem Pharmacol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T20:02:16Z","timestamp":1749412936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002253","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}